Amycolatopsins A-C: Antimycobacterial Glycosylated Polyketide Macrolides from the Australian Soil Amycolatopsis Sp. MST-108494
Overview
Pharmacology
Authors
Affiliations
A southern Australian soil isolate, Amycolatopsis sp. MST-108494, was subjected to a panel of fermentation and media optimization trials, supported by analytical chemical profiling, to detect and enhance production of a rare class of secondary metabolites. Chemical fractionation of two complementary fermentations yielded three new polyketides, identified by detailed spectroscopic analysis as the glycosylated macrolactones, amycolatopsins A (1), B (2) and C (3), closely related to the ammocidins and apoptolidins. Amycolatopsins 1 and 3 selectively inhibited growth of Mycobacterium bovis (BCG) and Mycobacterium tuberculosis (H37Rv) when compared with other Gram-positive or Gram-negative bacteria, with 3 exhibiting low levels of cytotoxicity toward mammalian cells. Thus, our data reveal promising structure activity relationship correlations where the antimycobacterial properties of amycolatopsins are enhanced by hydroxylation of the 6-Me (that is, 1 and 3), whereas mammalian cytotoxicity is decreased by hydrolysis of the disaccharide moiety (that is, 3).
Bioprospecting of Metabolites from Actinomycetes and their Applications.
Izhar S, Rizvi S, Afaq U, Fatima F, Siddiqui S Recent Pat Biotechnol. 2024; 18(4):273-287.
PMID: 38817008 DOI: 10.2174/0118722083269904231114154017.
Liu L, Liu Y, Liu S, Nikandrova A, Imamutdinova A, Lukianov D Front Microbiol. 2023; 14:1247001.
PMID: 37886074 PMC: 10599150. DOI: 10.3389/fmicb.2023.1247001.
Suertides A-C: selective antibacterial cyclic hexapeptides from Amycolatopsis sp. MST-135876v3.
Lacey H, Chen R, Vuong D, Fisher M, Lacey E, Rutledge P J Antibiot (Tokyo). 2022; 75(9):483-490.
PMID: 35882958 PMC: 9359914. DOI: 10.1038/s41429-022-00544-4.
Secondary Metabolites of the Genus : Structures, Bioactivities and Biosynthesis.
Song Z, Xu T, Wang J, Hou Y, Liu C, Liu S Molecules. 2021; 26(7).
PMID: 33810439 PMC: 8037709. DOI: 10.3390/molecules26071884.
Secondary Metabolites of Actinomycetes and their Antibacterial, Antifungal and Antiviral Properties.
Jakubiec-Krzesniak K, Rajnisz-Mateusiak A, Guspiel A, Ziemska J, Solecka J Pol J Microbiol. 2018; 67(3):259-272.
PMID: 30451442 PMC: 7256786. DOI: 10.21307/pjm-2018-048.